Schedule 13G ownership disclosure

SILO PHARMA INC COM

Common Stock, par value $0.0001 per share · CUSIP: 82711P201

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Renaissance Technologies LLC

    Shares: 37,500 · Class: 0.84%

  • Renaissance Technologies Holdings Corporation

    Shares: 37,500 · Class: 0.84%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-25-000019
Form type
SCHEDULE 13G/A
Filer
RENAISSANCE TECHNOLOGIES LLC
CIK
CIK 1037389
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub